Meret Oppenheim-Platz 1
Based in Basel, Doug leads Deloitte’s life sciences regulatory risk team in Switzerland. His extensive experience spans over more than 15 years of working with European medicines regulators and leading large scale and complex risk management programmes for global pharmaceutical clients. Doug’s principal interest lies in shaping strategies and business models that enable organisations to generate value from regulatory change. He specialises in designing and leading business transformational programmes that harness the regulatory agenda to deliver operational and productivity improvements.